226 related articles for article (PubMed ID: 21089596)
1. [Fragment-based lead discovery from smaller fragments to functional ligand].
Hatayama A; Habashita H
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1611-6. PubMed ID: 21089596
[No Abstract] [Full Text] [Related]
2. Recent progress in fragment-based lead discovery.
Schulz MN; Hubbard RE
Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
[TBL] [Abstract][Full Text] [Related]
3. [Mass spectrometric approach of proteomics].
Yamaguchi K
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1568-75. PubMed ID: 21089590
[No Abstract] [Full Text] [Related]
4. [Practice of fragment-based lead discovery by X-rays].
Yamano A
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1622-7. PubMed ID: 21089598
[No Abstract] [Full Text] [Related]
5. Cheminformatics approaches to analyze diversity in compound screening libraries.
Akella LB; DeCaprio D
Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
[TBL] [Abstract][Full Text] [Related]
6. Fragment screening using X-ray crystallography.
Davies TG; Tickle IJ
Top Curr Chem; 2012; 317():33-59. PubMed ID: 21678136
[TBL] [Abstract][Full Text] [Related]
7. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
8. Enhancements of screening collections to address areas of unmet medical need: an industry perspective.
Drewry DH; Macarron R
Curr Opin Chem Biol; 2010 Jun; 14(3):289-98. PubMed ID: 20413343
[TBL] [Abstract][Full Text] [Related]
9. Identification of lead compounds as antagonists of protein Bcl-xL with a diversity-oriented multidisciplinary approach.
Di Micco S; Vitale R; Pellecchia M; Rega MF; Riva R; Basso A; Bifulco G
J Med Chem; 2009 Dec; 52(23):7856-67. PubMed ID: 19852471
[TBL] [Abstract][Full Text] [Related]
10. Small-world phenomena in chemical library networks: application to fragment-based drug discovery.
Tanaka N; Ohno K; Niimi T; Moritomo A; Mori K; Orita M
J Chem Inf Model; 2009 Dec; 49(12):2677-86. PubMed ID: 19961207
[TBL] [Abstract][Full Text] [Related]
11. [Construction of natural products library and its usage for drug discovery].
Saito T; Nogawa T; Kato N; Kondoh Y; Osada H
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1551-6. PubMed ID: 21089587
[No Abstract] [Full Text] [Related]
12. [NMR in the fragment-based drug discovery].
Hanzawa H; Takizawa T
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1617-21. PubMed ID: 21089597
[No Abstract] [Full Text] [Related]
13. Ligand specificity, privileged substructures and protein druggability from fragment-based screening.
Barelier S; Krimm I
Curr Opin Chem Biol; 2011 Aug; 15(4):469-74. PubMed ID: 21411360
[TBL] [Abstract][Full Text] [Related]
14. Two 'Golden Ratio' indices in fragment-based drug discovery.
Orita M; Ohno K; Niimi T
Drug Discov Today; 2009 Mar; 14(5-6):321-8. PubMed ID: 19028598
[TBL] [Abstract][Full Text] [Related]
15. Fragment-based ligand discovery.
Fischer M; Hubbard RE
Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
[TBL] [Abstract][Full Text] [Related]
16. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry.
Tan LP; Wu H; Yang PY; Kalesh KA; Zhang X; Hu M; Srinivasan R; Yao SQ
Org Lett; 2009 Nov; 11(22):5102-5. PubMed ID: 19852491
[TBL] [Abstract][Full Text] [Related]
17. Bioprospecting microbial natural product libraries from the marine environment for drug discovery.
Liu X; Ashforth E; Ren B; Song F; Dai H; Liu M; Wang J; Xie Q; Zhang L
J Antibiot (Tokyo); 2010 Aug; 63(8):415-22. PubMed ID: 20606699
[TBL] [Abstract][Full Text] [Related]
18. The Interweaving of Cheminformatics and HTS.
Kümmel A; Parker CN
Methods Mol Biol; 2011; 672():435-57. PubMed ID: 20838979
[TBL] [Abstract][Full Text] [Related]
19. [Towards structure-based design of novel inhibitors for V-ATPase].
Murata T
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1654-9. PubMed ID: 21089603
[No Abstract] [Full Text] [Related]
20. Fragment-based approaches in drug discovery and chemical biology.
Scott DE; Coyne AG; Hudson SA; Abell C
Biochemistry; 2012 Jun; 51(25):4990-5003. PubMed ID: 22697260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
